Aurinia Pharmaceuticals
AUPH
AUPH
190 hedge funds and large institutions have $495M invested in Aurinia Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less funds holding
Funds holding: 197 → 190 (-7)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
Holders
190
Holding in Top 10
1
Calls
$28.4M
Puts
$22.1M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$12.2M | |
| 3 | +$8.57M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.14M |
| 5 |
Goldman Sachs
New York
|
+$4.74M |
Top Sellers
| 1 | -$7.77M | |
| 2 | -$4.35M | |
| 3 | -$3.74M | |
| 4 |
Two Sigma Advisers
New York
|
-$3.57M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$2.69M |